Antibody targeting as a thrombolytic strategy.
Haber
E
E
Harvard School of Public Health, Boston, Massachusetts 02115.
Bode
C
C
Matsueda
G R
GR
Reed
G L
GL
Runge
M S
MS
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D005337:Fibrin / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D010960:Plasminogen Activators / Q000008:administration & dosage* / Q000627:therapeutic use*; D017433:Protein Structure, Secondary; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods
D000906:Antibodies; D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D005337:Fibrin; D010960:Plasminogen Activators